Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 6
Rivastigmine in Alzheimer’s disease: Cognitive function and quality of life
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,673 | Dovepress* | 4,673+ | 1,312 | 5,985 | |
| Totals | 4,673 | 1,312 | 5,985 | ||
|
*Since 15 January 2008 +Since July 2016 |
|||||
View citations on Google Scholar